Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.34 - $3.96 $29,317 - $49,614
12,529 Added 35.31%
48,016 $174 Million
Q1 2024

May 14, 2024

SELL
$2.88 - $4.8 $13,440 - $22,401
-4,667 Reduced 11.62%
35,487 $114 Million
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.33 $37,267 - $57,409
10,771 Added 36.66%
40,154 $197 Million
Q3 2023

Feb 21, 2024

SELL
$5.07 - $8.44 $54,608 - $90,907
-10,771 Reduced 26.82%
29,383 $160 Million
Q3 2023

Nov 14, 2023

BUY
$5.07 - $8.44 $148,971 - $247,992
29,383 New
29,383 $160 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.